1. Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
   Shilong Zhang et al, 2023, Oncology Reports CrossRef
2. Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control
   Mahmoud E. Youssef et al, 2023, International Journal of Molecular Sciences CrossRef
3. In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation
   Muhammad Hamid Siddique et al, 2023, Pharmaceuticals CrossRef
4. Type Disparity in Sodium–Glucose Cotransporter-2 Inhibitors in Incidences of Renal Cell Carcinoma: A Propensity-Score-Matched Cohort Study
   Tsung-Kun Lin et al, 2024, Cancers CrossRef
5. cFLIPL alleviates myocardial ischemia‐reperfusion injury by regulating pyroptosis
   Dong Zhang et al, 2024, Cell Biology International CrossRef